Gsk (GLAXF) Current Taxes (2016 - 2025)
Historic Current Taxes for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to -$437.1 million.
- Gsk's Current Taxes rose 4077.37% to -$437.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$437.1 million, marking a year-over-year increase of 4077.37%. This contributed to the annual value of -$898.6 million for FY2024, which is 24449.44% down from last year.
- As of Q3 2025, Gsk's Current Taxes stood at -$437.1 million, which was up 4077.37% from -$775.1 million recorded in Q2 2025.
- Gsk's Current Taxes' 5-year high stood at $659.2 million during Q4 2021, with a 5-year trough of -$988.4 million in Q3 2021.
- Moreover, its 5-year median value for Current Taxes was -$574.5 million (2021), whereas its average is -$448.8 million.
- As far as peak fluctuations go, Gsk's Current Taxes skyrocketed by 8461.9% in 2022, and later plummeted by 24539.75% in 2024.
- Quarter analysis of 5 years shows Gsk's Current Taxes stood at $659.2 million in 2021, then decreased by 16.19% to $552.4 million in 2022, then increased by 12.33% to $620.6 million in 2023, then plummeted by 245.4% to -$902.3 million in 2024, then surged by 51.56% to -$437.1 million in 2025.
- Its last three reported values are -$437.1 million in Q3 2025, -$775.1 million for Q2 2025, and -$791.0 million during Q1 2025.